Skip to main content
    N

    NanoViricides Inc (NNVC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.24
    +0.00 (+0.41%)

    Market Cap: $31.41M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NanoViricides Inc (NNVC) Earnings: Report Dates and Results

    Updated Sep 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Jun 30, 2026, NanoViricides reported EPS of -$0.10, above the -$0.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    63%(15/24)
    Avg Surprise
    +4.89%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.08
    Range-$0.08 - -$0.08
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.080.0%
    60d ago-$0.080.0%
    30d ago-$0.080.0%
    7d ago-$0.080.0%
    Current-$0.08
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    NNVC's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 24 quarters below that had an estimate, NNVC beat 15, missed 5 and matched 4. The widest gap in the table came in the quarter ended Jun 30, 2023, when EPS landed 79.53% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$0.10-$0.11N/A+9.09%BeatN/A10 up, 1 downSep 28, 2026
    Mar 31, 2026-$0.09-$0.08-$0.08 - -$0.08-12.50%MissN/A10 up, 0 downMay 14, 2026
    Dec 31, 2025-$0.11-$0.08-$0.08 - -$0.08-37.50%MissN/A10 up, 0 downFeb 17, 2026
    Sep 30, 2025-$0.10-$0.18-$0.18 - -$0.18+44.44%BeatN/A10 up, 0 downNov 14, 2025
    Jun 30, 2025-$0.12-$0.20N/A+40.00%BeatN/AN/AN/ASep 3, 2025
    Mar 31, 2025-$0.14-$0.19N/A+26.32%BeatN/AN/AN/AMay 15, 2025
    Dec 31, 2024-$0.14-$0.18N/A+22.72%BeatN/AN/A0 up, 0 downFeb 14, 2025
    Sep 30, 2024-$0.23-$0.17N/A-34.12%MissN/AN/A0 up, 0 downNov 14, 2024
    Jun 30, 2024-$0.19-$0.20N/A+5.00%BeatN/AN/A0 up, 0 downSep 27, 2024
    Mar 31, 2024-$0.16-$0.19-$0.19 - -$0.19+15.79%BeatN/A10 up, 0 downMay 15, 2024
    Dec 31, 2023-$0.18-$0.19N/A+5.26%BeatN/AN/AN/AFeb 14, 2024
    Sep 30, 2023-$0.17-$0.17N/A0.00%In lineN/AN/A0 up, 0 downOct 13, 2023
    Jun 30, 2023-$0.31-$0.17N/A-79.53%MissN/AN/A0 up, 0 downAug 30, 2023
    Mar 31, 2023-$0.15-$0.17-$0.17 - -$0.17+11.76%BeatN/A10 up, 0 downMay 15, 2023
    Dec 31, 2022-$0.15-$0.16-$0.16 - -$0.16+6.25%BeatN/A10 up, 0 downFeb 14, 2023
    Sep 30, 2022-$0.14-$0.17-$0.17 - -$0.17+17.65%BeatN/A10 up, 0 downOct 13, 2022
    Jun 30, 2022-$0.15-$0.15N/A0.00%In lineN/AN/A0 up, 0 downAug 31, 2022
    Mar 31, 2022-$0.16-$0.22-$0.22 - -$0.22+27.27%BeatN/A10 up, 0 downMay 17, 2022
    Dec 31, 2021-$0.17-$0.22-$0.22 - -$0.22+22.73%BeatN/A10 up, 0 downFeb 14, 2022
    Sep 30, 2021-$0.23-$0.20-$0.20 - -$0.20-15.00%MissN/A1N/AOct 12, 2021
    Jun 30, 2021-$0.18N/AN/AN/AN/AN/AN/AN/ASep 1, 2021
    Mar 31, 2021-$0.19N/AN/AN/AN/AN/AN/AN/AMay 14, 2021
    Dec 31, 2020-$0.22N/AN/AN/AN/AN/AN/AN/AFeb 16, 2021
    Sep 30, 2020-$0.22N/AN/AN/AN/AN/AN/AN/AOct 13, 2020
    Jun 30, 2020-$0.23N/AN/AN/AN/AN/AN/AN/ASep 2, 2020
    Mar 31, 2020-$1.24N/AN/AN/AN/AN/AN/AN/AJun 22, 2020
    Dec 31, 2019-$0.50-$0.60N/A+16.67%BeatN/AN/AN/AFeb 14, 2020
    Sep 30, 2019-$0.41N/AN/AN/AN/AN/AN/AN/ANov 15, 2019
    Jun 30, 2019-$0.60-$0.80N/A+25.00%BeatN/AN/AN/AAug 23, 2019
    Mar 31, 2019-$0.60-$0.60N/A0.00%In lineN/AN/AN/AMay 15, 2019
    Dec 31, 2018-$0.60-$0.60N/A0.00%In lineN/AN/AN/AFeb 19, 2019
    Sep 30, 2018-$0.60N/AN/AN/AN/AN/AN/AN/AOct 12, 2018
    Jun 30, 2018-$0.02N/AN/AN/AN/AN/AN/AN/AAug 29, 2018
    Mar 31, 2018-$0.03N/AN/AN/AN/AN/AN/AN/AMay 21, 2018
    Dec 31, 2017-$0.04N/AN/AN/AN/AN/AN/AN/AFeb 21, 2018
    Sep 30, 2017-$0.03N/AN/AN/AN/AN/AN/AN/ANov 14, 2017
    Jun 30, 2017-$0.04N/AN/AN/AN/AN/AN/AN/ASep 28, 2017
    Mar 31, 2017-$0.05N/AN/AN/AN/AN/AN/AN/AMay 15, 2017
    Dec 31, 2016-$0.53N/AN/AN/AN/AN/AN/AN/AFeb 14, 2017
    Sep 30, 2016-$1.05N/AN/AN/AN/AN/AN/AN/ANov 15, 2016
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was -$0.40, after -$0.63 the year before. It was -$1.67 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026-$0.40N/A
    Jun 30, 2025-$0.63N/A
    Jun 30, 2024-$0.70N/A
    Jun 30, 2023-$0.75N/A
    Jun 30, 2022-$0.71N/A
    Jun 30, 2021-$0.81N/A
    Jun 30, 2020-$2.38N/A
    Jun 30, 2019-$2.40N/A
    Jun 30, 2018-$0.12N/A
    Jun 30, 2017-$1.67N/A

    Frequently Asked Questions About NNVC

    Did NNVC beat earnings estimates last quarter?

    Yes. NanoViricides reported EPS of -$0.10 for the quarter ended Jun 30, 2026, above the -$0.11 estimate, a 9.09% surprise.

    What EPS do analysts expect from NNVC next quarter?

    The consensus EPS estimate for NanoViricides for the quarter ending Dec 31, 2026 is -$0.08 from 1 analyst, with estimates from -$0.08 to -$0.08.

    How often does NNVC beat earnings estimates?

    NanoViricides beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +7.31%.